Bryan Kobel

Bryan Kobel

Chief Executive Officer presso TC BIOPHARM (HOLDINGS) PLC

Patrimonio netto: 773 $ in data 30/11/2023

44 anni
Finance
Health Technology
Consumer Services

Profilo

Bryan Kobel is currently the Chief Executive Officer & Director at TC Biopharm (Holdings) Plc, as well as the CEO-Biopharm North America and Chief Executive Officer at TC BioPharm (North America), Inc. He previously worked as the Managing Director at Laidlaw & Co. (UK) Ltd.
from 2012 to 2017, Managing Director at The Alberleen Group LLC from 2018 to 2020, and Head-Capital Markets at R.F.
Lafferty & Co., Inc. from 2017 to 2018.
He also served as the Head-Healthcare Investment Banking at HUTN, Inc. Mr. Kobel received his undergraduate degree from Franklin & Marshall College.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValorizzazioneData di valutazione
06/02/2024 2 101 ( 0.22% ) 773 $ 30/11/2023

Posizioni attive di Bryan Kobel

SocietàPosizioneInizio
TC BIOPHARM (HOLDINGS) PLC Chief Executive Officer 01/06/2021
Corporate Officer/Principal -
TC BioPharm (North America), Inc. Chief Executive Officer 01/06/2021
Tutte le posizioni attive di Bryan Kobel

Precedenti posizioni note di Bryan Kobel

SocietàPosizioneFine
Corporate Officer/Principal 01/10/2020
Corporate Officer/Principal 01/06/2018
Corporate Officer/Principal 01/04/2017
HUTN, INC. Corporate Officer/Principal -
Vedi nel dettaglio l'esperienza di Bryan Kobel

Formazione di Bryan Kobel

Franklin & Marshall College Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Bryan Kobel

Relazioni

17

Relazioni di 1° grado

8

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa2
HUTN, INC.

Finance

TC BIOPHARM (HOLDINGS) PLC

Health Technology

Aziende private5

Finance

Finance

Finance

Health Technology

TC BioPharm (North America), Inc.

Vedi le connessioni aziendali